SPECIFICBIOLOGICS Trademark

Trademark Overview


On Friday, September 9, 2022, a trademark application was filed for SPECIFICBIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the SPECIFICBIOLOGICS trademark a serial number of 97585097. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, November 4, 2024. This trademark is owned by Specific Biologics Inc.. The SPECIFICBIOLOGICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical treatment of genetic diseases and disorders, cystic fibrosis and cancer
specificbiologics

General Information


Serial Number97585097
Word MarkSPECIFICBIOLOGICS
Filing DateFriday, September 9, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, November 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Description of MarkThe mark consists of a standard lowercase lettering of the term "SpecificBiologics" with the bolded word "Specific" colored a shade of blue and the unbolded word "Biologics" colored a shade of black. Both the "S" in "Specific" and the "B" in "Biologics" are uppercase letters. A 4-pointed pinwheel appears immediately to the left of the term and is larger in size. The top left and lower right points of the pinwheel are colored silver whereas the top right and lower left points of the pinwheel are colored the same shade of blue as the word "Specific". The top two points of the pinwheel curve to the right whereas the bottom two points of the pinwheel curve to the left.
Pseudo MarkSPECIFIC BIOLOGICS
Indication of Colors claimedThe color(s) blue, silver, and black is/are claimed as a feature of the mark.
Goods and ServicesMedical treatment of genetic diseases and disorders, cystic fibrosis and cancer
NOT AVAILABLE"SPECIFIC BIOLOGICS"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 26, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpecific Biologics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G0B
CA

Party NameSpecific Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G0B
CA

Trademark Events


Event DateEvent Description
Tuesday, September 13, 2022NEW APPLICATION ENTERED
Monday, September 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 27, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 23, 2023ASSIGNED TO EXAMINER
Wednesday, June 28, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 28, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 22, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, September 22, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, December 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 4, 2024SOU EXTENSION 1 FILED
Monday, November 4, 2024SOU EXTENSION 1 GRANTED